GULF RESOURCES, INC. annual report, FY2021

Gulf Resources, Inc. — FY2021 Form 10-K

Reporting period: Fiscal year ended December 31, 2021; filed April 12, 2022. This is an annual report, not a standalone fourth-quarter report. Gulf Resources is a Nevada holding company whose operating subsidiaries are based in China. Its principal active businesses were bromine and crude salt; chemical production remained shut during relocation, and natural gas production was suspended pending approvals.

Financial performance and condition

MetricFY2021FY2020
Revenue$55.03 million$28.21 million
Gross profit / margin$27.90 million / 51%$8.79 million / 31%
Operating income (loss)$5.21 million($9.68 million)
Income (loss) before tax$5.37 million($9.53 million)
Income tax expense (benefit)$6.30 million($1.11 million)
Net loss($0.92 million); loss per share $0.09($8.42 million); loss per share $0.87
Operating cash flow$23.31 million$9.31 million
Investing cash flow($30.09 million)($21.72 million)
Cash at year-end$95.77 million$94.22 million
  • Revenue grew 95%. Bromine revenue increased 78% to $48.87 million, reflecting 24% higher volume sold and a 57% increase in average selling price. Crude salt revenue rose 101% to $6.08 million, primarily on higher prices. Chemical and natural gas revenue was zero; equipment-lease revenue was $78,948.
  • Bromine gross margin rose to 53% from 37%; crude salt moved to a 30% margin from a 15% loss. Overall gross margin improved to 51% from 31%.
  • Despite positive operating income, the company reported a net loss, principally because of $6.30 million income tax expense. The filing also cites deferred-tax effects, depreciation at inactive factories, and $3.13 million of stock-based compensation as factors affecting results.
  • Cash from operations increased, but $30.09 million of property, plant and equipment purchases exceeded operating cash flow. Financing cash outflow was $0.29 million; favorable foreign-exchange effects added $8.62 million to reported cash movement.
  • Year-end current assets were $115.43 million and current liabilities $13.89 million. Cash was $95.77 million. Total liabilities were $23.22 million, including $2.00 million of finance lease liabilities and $8.06 million of operating lease liabilities; the filing does not report material conventional borrowing.
  • Accounts receivable rose to $14.53 million from $6.52 million; the company said all year-end receivables were collected from January through March 2022. Three customers represented approximately 56.6% of total 2021 revenue, and the top five represented 64.8%. The company sourced all raw materials from its top five suppliers.

Material changes and operational developments

  • Four bromine facilities operated during 2021. Bromine sold increased to 7,379 tonnes from 5,957 tonnes, while crude salt sold increased to 181,720 tonnes from 174,722 tonnes. Company-wide bromine capacity was reported as 31,506 tonnes annually, with 25% utilization in 2021.
  • All Shouguang bromine facilities were temporarily closed from December 28, 2021 through February 21, 2022 under a government seasonal closure; the company reported that its four operating facilities restarted as scheduled.
  • Factories No. 2, No. 8 and No. 10 remained unapproved for production. Management said it expected approval for at least one, and potentially more, closed factories in 2022; this was an expectation, not a confirmed approval.
  • The chemical business had no revenue while its old plants remained closed and the replacement factory was under construction. Relocation costs reached $45.58 million by year-end; total project cost was estimated at about $64 million. Civil works were substantially completed, but equipment delivery, installation and testing were delayed by supply-chain issues and electricity restrictions. In February 2022, management said restrictions appeared to be easing and it intended to proceed with equipment delivery and trial production.
  • The Daying natural gas and brine project remained suspended pending project, safety, environmental, land and licensing approvals. No natural gas was sold in either year.
  • Capital expenditure commitments were reported at $54.77 million, largely payable within 12 months. Management said cash and operating cash flows should cover anticipated needs for the next 12 months.

Outlook, risks, contingencies and unusual items

  • Outlook: No formal numerical revenue or earnings guidance was provided. Management expressed optimism about the future chemical factory’s potential but its restart timing and profitability remain uncertain. The company does not expect to pay dividends in the foreseeable future.
  • Regulatory and operating risk: Production depends on Chinese safety, environmental, land-use, planning and mineral-rights approvals. The company’s bromine mining certificate was renewed in July 2021 with a 24,000-tonne annual production limit. Government actions have previously closed, demolished or delayed facilities.
  • Legal contingency: 2018 administrative decisions and 2019 court rulings concerning land use at six factories called for land restoration, demolition or confiscation of facilities, and aggregate penalties of about RMB1.3 million. Management considered enforcement and material loss remote and recorded no accrual. The filing says enforcement action could still cause liabilities or operational disruption.
  • China and capital-markets risk: All operations and substantially all revenue are in China. The filing highlights regulatory uncertainty, foreign-exchange and dividend-transfer restrictions, PRC legal-enforcement limitations, and potential HFCAA-related trading or delisting risk. The auditor was U.S.-based and, according to the filing, was not identified in the PCAOB’s December 2021 determination concerning firms headquartered in mainland China or Hong Kong.
  • Tax and asset judgments: Deferred tax assets were $12.90 million, down from $18.59 million; realization depends on future taxable income. Property, plant and equipment accounted for more than half of total assets and was identified as a critical audit matter. The 2021 audit opinion was unqualified; management reported effective disclosure controls and internal control over financial reporting, without an auditor attestation on internal controls.
  • Unusual item to reconcile: The notes state that $57.39 million of plant and machinery, wells and aqueducts was written off in 2021, while the balance sheet reports net property, plant and equipment increasing to $162.66 million from $148.95 million and the notes report no 2021 impairment indicators. The filing text does not clearly reconcile these disclosures.
  • Reporting inconsistencies: Some MD&A passages give cash-flow or net-loss explanations that do not match the audited statements. The audited financial statements report a $0.92 million net loss and $23.31 million operating cash flow; verify these against the full filing and any subsequent disclosures.

Investor verification priorities

  1. Reconcile the reported $57.39 million asset write-off with the property, plant and equipment balances, cash-flow disclosures and related accounting notes.
  2. Confirm the status and remaining cost, committed payments, equipment delivery and expected commissioning schedule for the replacement chemical factory.
  3. Verify current approvals, operating limits and production status for each bromine facility, including the three sites still awaiting approval, and assess the land-use rulings and contingency exposure.
  4. Check collection of receivables, customer and supplier concentration, and the location, accessibility and transferability of the $95.77 million cash balance in China.
  5. Assess whether operating cash generation can fund the $54.77 million capital commitment while maintaining liquidity, and whether deferred tax assets can be realized.